Sarah Walter is the Program Administrator for the Alzheimer’s Clinical Trials Consortium (ACTC) and for the Alzheimer’s Therapeutic Research Institute (ATRI) at the University of Southern California. Her role is to ensure efficient operation of the consortium and to foster collaboration both within the community and with external partners. She draws on her experience across the spectrum of clinical trials, from participant recruitment, conducting assessments, to clinical monitoring, data management, and project and program administration. She facilitates communication between ACTC Leadership and Committees, oversees the review and development of ACTC Projects, and Chairs the Research Participant Advisory Board. Ms. Walter also leads initiatives on Site and Study Metrics, establishing the ACTC Neuropathology Infrastructure, as well as Site Process Improvement, Networking and Support.